Zacks Research Forecasts Lower Earnings for Tenet Healthcare

Key Points

• Zacks Research has reduced its Q3 2026 earnings estimate for Tenet Healthcare to $3.56 EPS, down from $3.57, maintaining a "Hold" rating on the stock.
• Despite the lowered earnings forecast, Tenet Healthcare's Q2 2027 earnings estimate is projected at $4.42 EPS, with a current full-year earnings consensus estimate of $12.24 EPS.
• The stock has shown positive performance, having recently posted earnings of $4.02 EPS, exceeding consensus estimates and contributing to a 3.2% year-over-year revenue increase.

Tenet Healthcare Corporation (NYSE:THC - Free Report) - Analysts at Zacks Research decreased their Q3 2026 earnings per share estimates for Tenet Healthcare in a research report issued on Tuesday, October 7th. Zacks Research analyst Team now forecasts that the company will post earnings per share of $3.56 for the quarter, down from their prior forecast of $3.57. Zacks Research currently has a "Hold" rating on the stock. The consensus estimate for Tenet Healthcare's current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare's Q4 2026 earnings at $4.03 EPS and Q2 2027 earnings at $4.42 EPS.

Tenet Healthcare (NYSE:THC - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The company reported $4.02 earnings per share for the quarter, beating analysts' consensus estimates of $2.84 by $1.18. The company had revenue of $5.27 billion for the quarter, compared to analyst estimates of $5.16 billion. Tenet Healthcare had a return on equity of 24.69% and a net margin of 7.17%.The company's revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter last year, the company earned $2.31 earnings per share. Tenet Healthcare has set its FY 2025 guidance at 15.550-16.210 EPS.

THC has been the subject of a number of other reports. KeyCorp raised their target price on Tenet Healthcare from $205.00 to $225.00 and gave the stock an "overweight" rating in a research report on Wednesday. Mizuho raised their target price on Tenet Healthcare from $184.00 to $194.00 and gave the stock an "outperform" rating in a research report on Friday, July 11th. Cantor Fitzgerald reiterated an "overweight" rating and issued a $190.00 price target on shares of Tenet Healthcare in a research report on Tuesday. Robert W. Baird reduced their price target on Tenet Healthcare from $195.00 to $167.00 and set a "neutral" rating for the company in a research report on Friday, July 25th. Finally, JPMorgan Chase & Co. lifted their price objective on Tenet Healthcare from $190.00 to $200.00 and gave the company an "overweight" rating in a research note on Monday, August 4th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, Tenet Healthcare has an average rating of "Moderate Buy" and a consensus target price of $201.69.

Tenet Healthcare Stock Performance

Shares of Tenet Healthcare stock opened at $200.33 on Thursday. The business's fifty day simple moving average is $184.47 and its 200 day simple moving average is $163.80. The firm has a market capitalization of $17.70 billion, a P/E ratio of 12.83, a price-to-earnings-growth ratio of 0.88 and a beta of 1.52. Tenet Healthcare has a 12 month low of $109.82 and a 12 month high of $207.14. The company has a current ratio of 1.71, a quick ratio of 1.63 and a debt-to-equity ratio of 2.39.

Institutional Trading of Tenet Healthcare

Several institutional investors have recently added to or reduced their stakes in THC. Nuveen LLC purchased a new stake in Tenet Healthcare during the 1st quarter valued at $218,549,000. Ameriprise Financial Inc. lifted its holdings in shares of Tenet Healthcare by 348.4% during the 1st quarter. Ameriprise Financial Inc. now owns 1,962,314 shares of the company's stock valued at $263,905,000 after buying an additional 1,524,642 shares during the period. Norges Bank bought a new position in shares of Tenet Healthcare during the 2nd quarter valued at $206,981,000. Boston Partners lifted its holdings in shares of Tenet Healthcare by 95.0% during the 2nd quarter. Boston Partners now owns 2,267,142 shares of the company's stock valued at $398,949,000 after buying an additional 1,104,500 shares during the period. Finally, Alliancebernstein L.P. raised its holdings in Tenet Healthcare by 375.7% in the 2nd quarter. Alliancebernstein L.P. now owns 790,254 shares of the company's stock worth $139,085,000 after purchasing an additional 624,125 shares during the period. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Tenet Healthcare

In related news, CEO Saumya Sutaria sold 78,762 shares of the business's stock in a transaction dated Wednesday, September 10th. The stock was sold at an average price of $190.78, for a total transaction of $15,026,214.36. Following the transaction, the chief executive officer owned 368,683 shares in the company, valued at $70,337,342.74. The trade was a 17.60% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Lisa Y. Foo sold 8,000 shares of the company's stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $179.53, for a total value of $1,436,240.00. Following the transaction, the executive vice president owned 20,878 shares in the company, valued at $3,748,227.34. This trade represents a 27.70% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 90,722 shares of company stock worth $17,161,015 in the last 90 days. Company insiders own 0.81% of the company's stock.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.